{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T21:15:07Z","timestamp":1780780507791,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00347-023-01820-w","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T19:00:00Z","timestamp":1675969200000},"page":"262-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnose und Therapie der malignen Lidtumoren","Diagnosis and treatment of malignant eyelid tumors"],"prefix":"10.1007","volume":"120","author":[{"given":"S.","family":"Gniesmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Sonntag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schiemenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Heindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Varde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Emmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kakkassery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"1820_CR1","volume-title":"Dermatoscopy","author":"W Adamski","year":"2022","unstructured":"Adamski\u00a0W, Adamska\u00a0K (2022) Pigmented lesions of the eyelid margin. In: Pietkiewicz\u00a0P (Hrsg) Dermatoscopy. IntechOpen, London"},{"issue":"1","key":"1820_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S1470-2045(13)70530-8","volume":"15","author":"F Bath-Hextall","year":"2014","unstructured":"Bath-Hextall\u00a0F, Ozolins\u00a0M, Armstrong\u00a0SJ, Colver\u00a0GB, Perkins\u00a0W, Miller\u00a0PSJ, Williams\u00a0HC (2014) Surgical excision versus imiquimod 5\u202f% cream for nodular and superficial basal-cell carcinoma (SINS): a\u00a0multicentre, non-inferiority, randomised controlled trial. Lancet Oncol 15(1):96\u2013105. https:\/\/doi.org\/10.1016\/S1470-2045(13)70530-8","journal-title":"Lancet Oncol"},{"key":"1820_CR3","volume-title":"S2k \u2013 Leitlinie \u2013 Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut)","author":"JC Becker","year":"2018","unstructured":"Becker\u00a0JC, Eigentler\u00a0T, Frerich\u00a0B, Gambichler\u00a0T, Grabbe\u00a0S, H\u00f6ller\u00a0U, Klumpp\u00a0B, Loquai\u00a0C, Krause-Bergmann\u00a0A, M\u00fcller-Richter\u00a0U, Pf\u00f6hler\u00a0C, Schneider-Burrus\u00a0S, Stang\u00a0A, Terheyden\u00a0P, Ugurel\u00a0S, Veith\u00a0J, Mauch\u00a0C (2018) S2k \u2013 Leitlinie \u2013 Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) (Update 2018)"},{"issue":"2","key":"1820_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12105-016-0707-8","volume":"10","author":"JO Black","year":"2016","unstructured":"Black\u00a0JO (2016) Xeroderma Pigmentosum. Head Neck Pathol 10(2):139\u2013144. https:\/\/doi.org\/10.1007\/s12105-016-0707-8","journal-title":"Head Neck Pathol"},{"issue":"1","key":"1820_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000511215","volume":"7","author":"P Brunetti","year":"2021","unstructured":"Brunetti\u00a0P, Margo\u00a0CE, French\u00a0DD (2021) Incidence of cutaneous melanoma of eyelid analysis of the surveillance, epidemiology, and end results database. Ocul Oncol Pathol 7(1):66\u201369. https:\/\/doi.org\/10.1159\/000511215","journal-title":"Ocul Oncol Pathol"},{"issue":"5","key":"1820_CR6","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10792-018-0925-z","volume":"39","author":"MV Cicinelli","year":"2019","unstructured":"Cicinelli\u00a0MV, Kaliki\u00a0S (2019) Ocular sebaceous gland carcinoma: an update of the literature. Int Ophthalmol 39(5):1187\u20131197. https:\/\/doi.org\/10.1007\/s10792-018-0925-z","journal-title":"Int Ophthalmol"},{"key":"1820_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.77","volume-title":"Stellungnahme zur Nutzenbewertung gem\u00e4\u00df \u00a7 35a SGB V Avelumab","author":"Deutsche Gesellschaft f\u00fcr H\u00e4matologie und medizinische Onkologie","year":"2020","unstructured":"Deutsche Gesellschaft f\u00fcr H\u00e4matologie und medizinische Onkologie (2020) Stellungnahme zur Nutzenbewertung gem\u00e4\u00df \u00a7 35a SGB V Avelumab https:\/\/doi.org\/10.1038\/nrdp.2017.77"},{"key":"1820_CR8","volume-title":"Stellungnahme zur Nutzenbewertung des G-BA von Arzneimitteln gem\u00e4\u00df \u00a7 35a SGB V Cemiplimab (neues Anwendungsgebiet, Basalzellkarzinom, fortgeschritten oder metastasiert, nach Vortherapie)","author":"Deutsche Gesellschaft f\u00fcr H\u00e4matologie und medizinische Onkologie","year":"2021","unstructured":"Deutsche Gesellschaft f\u00fcr H\u00e4matologie und medizinische Onkologie (2021) Stellungnahme zur Nutzenbewertung des G\u2011BA von Arzneimitteln gem\u00e4\u00df \u00a7 35a SGB V Cemiplimab (neues Anwendungsgebiet, Basalzellkarzinom, fortgeschritten oder metastasiert, nach Vortherapie)"},{"issue":"1","key":"1820_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40425-018-0357-3","volume":"6","author":"E Domingo-Musibay","year":"2018","unstructured":"Domingo-Musibay\u00a0E, Murugan\u00a0P, Giubellino\u00a0A, Sharma\u00a0S, Steinberger\u00a0D, Yuan\u00a0J, Hunt\u00a0MA, Lou\u00a0E, Miller\u00a0JS (2018) Near complete response to pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma. J\u00a0Immunother Cancer 6(1):58. https:\/\/doi.org\/10.1186\/s40425-018-0357-3","journal-title":"J Immunother Cancer"},{"issue":"5","key":"1820_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/IOP.0000000000000554","volume":"32","author":"MD Elia","year":"2016","unstructured":"Elia\u00a0MD, Lally\u00a0SE, Hanlon\u00a0AM, Choi\u00a0JN, Servat\u00a0JJ, Shields\u00a0JA, Shields\u00a0CL, Levin\u00a0F (2016) Periocular melanoma in situ treated with Imiquimod. Ophthalmic Plast Reconstr Surg 32(5):371\u2013373. https:\/\/doi.org\/10.1097\/IOP.0000000000000554","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"1820_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4081\/oncol.2020.420","volume":"14","author":"A Furdova","year":"2020","unstructured":"Furdova\u00a0A, Kapitanova\u00a0K, Kollarova\u00a0A, Sekac\u00a0J (2020) Periocular basal cell carcinoma\u2014clinical perspectives. Oncol Rev 14(1):420. https:\/\/doi.org\/10.4081\/oncol.2020.420","journal-title":"Oncol Rev"},{"key":"1820_CR12","volume-title":"Muir-Torre syndrome","author":"JT Gay","year":"2022","unstructured":"Gay\u00a0JT, Troxell\u00a0T, Gross\u00a0GP (2022) Muir-Torre syndrome. StatPearls, Treasure Island (FL)"},{"issue":"5","key":"1820_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jaad.2003.11.066","volume":"50","author":"J Geisse","year":"2004","unstructured":"Geisse\u00a0J, Caro\u00a0I, Lindholm\u00a0J, Golitz\u00a0L, Stampone\u00a0P, Owens\u00a0M (2004) Imiquimod 5\u202f% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J\u00a0Am Acad Dermatol 50(5):722\u2013733. https:\/\/doi.org\/10.1016\/j.jaad.2003.11.066","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1820_CR14","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s00262-020-02832-0","volume":"70","author":"V Glutsch","year":"2021","unstructured":"Glutsch\u00a0V, Kneitz\u00a0H, Gesierich\u00a0A, Goebeler\u00a0M, Haferkamp\u00a0S, Becker\u00a0JC, Ugurel\u00a0S, Schilling\u00a0B (2021) Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma. Cancer Immunol Immunother 70(7):2087\u20132093. https:\/\/doi.org\/10.1007\/s00262-020-02832-0","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"1820_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0009-9260(86)80161-1","volume":"37","author":"VL Hall","year":"1986","unstructured":"Hall\u00a0VL, Leppard\u00a0BJ, McGill\u00a0J, Kesseler\u00a0ME, White\u00a0JE, Goodwin\u00a0P (1986) Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 37(1):33\u201334. https:\/\/doi.org\/10.1016\/s0009-9260(86)80161-1","journal-title":"Clin Radiol"},{"issue":"8","key":"1820_CR16","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bjps.2013.04.032","volume":"66","author":"V Harish","year":"2013","unstructured":"Harish\u00a0V, Bond\u00a0JS, Scolyer\u00a0RA, Haydu\u00a0LE, Saw\u00a0RPM, Quinn\u00a0MJ, Benger\u00a0RS, Uren\u00a0RF, Stretch\u00a0JR, Shannon\u00a0KF, Thompson\u00a0JF (2013) Margins of excision and prognostic factors for cutaneous eyelid melanomas. J\u00a0Plast Reconstr Aesthet Surg 66(8):1066\u20131073. https:\/\/doi.org\/10.1016\/j.bjps.2013.04.032","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"11","key":"1820_CR17","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","volume":"23","author":"KL Harms","year":"2016","unstructured":"Harms\u00a0KL, Healy\u00a0MA, Nghiem\u00a0P, Sober\u00a0AJ, Johnson\u00a0TM, Bichakjian\u00a0CK, Wong\u00a0SL (2016) Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system. Ann Surg Oncol 23(11):3564\u20133571. https:\/\/doi.org\/10.1245\/s10434-016-5266-4","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1820_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.hoc.2018.09.005","volume":"33","author":"RI Hartman","year":"2019","unstructured":"Hartman\u00a0RI, Lin\u00a0JY (2019) Cutaneous melanoma\u2014a review in detection, staging, and management. Hematol Oncol Clin North Am 33(1):25\u201338. https:\/\/doi.org\/10.1016\/j.hoc.2018.09.005","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"1820_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jamaophthalmol.2013.6077","volume":"132","author":"HM Herbert","year":"2014","unstructured":"Herbert\u00a0HM, Sun\u00a0MT, Selva\u00a0D, Fernando\u00a0B, Saleh\u00a0GM, Beaconsfield\u00a0M, Collin\u00a0R, Uddin\u00a0J, Meligonis\u00a0G, Leatherbarrow\u00a0B, Ataullah\u00a0S, Irion\u00a0L, McLean\u00a0CJ, Huilgol\u00a0SC, Davis\u00a0G, Sullivan\u00a0TJ (2014) Merkel cell carcinoma of the eyelid: management and prognosis. JAMA Ophthalmol 132(2):197\u2013204. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.6077","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"1820_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00347-016-0355-0","volume":"114","author":"R Hoerster","year":"2017","unstructured":"Hoerster\u00a0R, Schlaak\u00a0M, Koch\u00a0KR, Ortmann\u00a0M, Mauch\u00a0C, Heindl\u00a0LM (2017) Merkel-Zell-Karzinom des Augenlids \u2013 eine h\u00e4ufig verkannte Diagnose : Klinische Aspekte und Behandlungsmethoden. Ophthalmologe 114(2):134\u2013139. https:\/\/doi.org\/10.1007\/s00347-016-0355-0","journal-title":"Ophthalmologe"},{"issue":"9","key":"1820_CR21","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/bjc.1998.666","volume":"78","author":"S Holmes","year":"1998","unstructured":"Holmes\u00a0S (1998) Basal cell carcinoma of the face: surgery or radiotherapy? Results of a\u00a0randomized study. Br J Cancer 78(9):1257. https:\/\/doi.org\/10.1038\/bjc.1998.666","journal-title":"Br J Cancer"},{"key":"1820_CR22","volume-title":"Basalzellkarzinom-der-Haut","author":"B Lang","year":"2018","unstructured":"Lang\u00a0B et al (2018) Basalzellkarzinom-der-Haut"},{"key":"1820_CR23","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2018) S3 Leitlinie Aktinische Keratose und Plattenepithelkarzinom der Haut, Langversion 0.1 (Konsultationsfassung). https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/aktinische-keratosen-und- plattenepithelkarzinom-der-haut\/. Zugegriffen: 7. Juni 2022 (AWMF Registernummer: 032\/022OL)"},{"issue":"2","key":"1820_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1442-9071.2006.01411.x","volume":"35","author":"V Limawararut","year":"2007","unstructured":"Limawararut\u00a0V, Leibovitch\u00a0I, Sullivan\u00a0T, Selva\u00a0D (2007) Periocular squamous cell carcinoma. Clin Experiment Ophthalmol 35(2):174\u2013185. https:\/\/doi.org\/10.1111\/j.1442-9071.2006.01411.x","journal-title":"Clin Experiment Ophthalmol"},{"issue":"3","key":"1820_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.survophthal.2018.12.002","volume":"64","author":"N Mancera","year":"2019","unstructured":"Mancera\u00a0N, Smalley\u00a0KSM, Margo\u00a0CE (2019) Melanoma of the eyelid and periocular skin: histopathologic classification and molecular pathology. Surv Ophthalmol 64(3):272\u2013288. https:\/\/doi.org\/10.1016\/j.survophthal.2018.12.002","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"1820_CR26","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/cancers6021128","volume":"6","author":"H Merritt","year":"2014","unstructured":"Merritt\u00a0H, Sniegowski\u00a0MC, Esmaeli\u00a0B (2014) Merkel cell carcinoma of the eyelid and periocular region. Cancers (Basel) 6(2):1128\u20131137. https:\/\/doi.org\/10.3390\/cancers6021128","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1820_CR27","doi-asserted-by":"publisher","first-page":"101046","DOI":"10.1016\/j.disamonth.2020.101046","volume":"66","author":"JM Moran","year":"2020","unstructured":"Moran\u00a0JM, Phelps\u00a0PO (2020) Periocular skin cancer: diagnosis and management. Dis Mon 66(10):101046. https:\/\/doi.org\/10.1016\/j.disamonth.2020.101046","journal-title":"Dis Mon"},{"key":"1820_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14307_g","author":"L Onkologie","year":"2020","unstructured":"Onkologie\u00a0L (2020) S3 \u2013 Leitlinie zur Diagnostik, Therapie und Nachsorge des Melanoms. J\u00a0Dtsch Dermatol Ges. https:\/\/doi.org\/10.1111\/ddg.14307_g","journal-title":"J Dtsch Dermatol Ges"},{"issue":"12","key":"1820_CR29","doi-asserted-by":"publisher","first-page":"e699","DOI":"10.1016\/S1470-2045(19)30673-4","volume":"20","author":"JL Owen","year":"2019","unstructured":"Owen\u00a0JL, Kibbi\u00a0N, Worley\u00a0B et al (2019) Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol 20(12):e699\u2013e714. https:\/\/doi.org\/10.1016\/S1470-2045(19)30673-4","journal-title":"Lancet Oncol"},{"issue":"3","key":"1820_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ad.2017.07.018","volume":"109","author":"I Palacios-\u00c1lvarez","year":"2018","unstructured":"Palacios-\u00c1lvarez\u00a0I, Gonz\u00e1lez-Sarmiento\u00a0R, Fern\u00e1ndez-L\u00f3pez\u00a0E (2018) S\u00edndrome de Gorlin. Actas Dermosifiliogr 109(3):207\u2013217. https:\/\/doi.org\/10.1016\/j.ad.2017.07.018","journal-title":"Actas Dermosifiliogr"},{"issue":"9","key":"1820_CR31","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0161-6420(01)00701-1","volume":"108","author":"GB Peters","year":"2001","unstructured":"Peters\u00a0GB, Meyer\u00a0DR, Shields\u00a0JA, Custer\u00a0PL, Rubin\u00a0PA, Wojno\u00a0TH, Bersani\u00a0TA, Tanenbaum\u00a0M (2001) Management and prognosis of merkel cell carcinoma of the eyelid. Ophthalmology 108(9):1575\u20131579. https:\/\/doi.org\/10.1016\/S0161-6420(01)00701-1","journal-title":"Ophthalmology"},{"issue":"2","key":"1820_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/bjophthalmol-2015-308261","volume":"101","author":"GM Saleh","year":"2017","unstructured":"Saleh\u00a0GM, Desai\u00a0P, Collin\u00a0JRO, Ives\u00a0A, Jones\u00a0T, Hussain\u00a0B (2017) Incidence of eyelid basal cell carcinoma in England: 2000\u20132010. Br J Ophthalmol 101(2):209\u2013212. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-308261","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"1820_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jfo.2020.07.019","volume":"44","author":"SY Sendul","year":"2021","unstructured":"Sendul\u00a0SY, Akpolat\u00a0C, Yilmaz\u00a0Z, Eryilmaz\u00a0OT, Guven\u00a0D, Kabukcuoglu\u00a0F (2021) Clinical and pathological diagnosis and comparison of benign and malignant eyelid tumors. J\u00a0Fr Ophtalmol 44(4):537\u2013543. https:\/\/doi.org\/10.1016\/j.jfo.2020.07.019","journal-title":"J Fr Ophtalmol"},{"key":"1820_CR34","doi-asserted-by":"publisher","first-page":"4858636","DOI":"10.1155\/2020\/4858636","volume":"2020","author":"Y Shan","year":"2020","unstructured":"Shan\u00a0Y, Xu\u00a0Y, Lu\u00a0Y, Chen\u00a0M, Cao\u00a0J, Wang\u00a0Y, Lin\u00a0X, Ye\u00a0J (2020) Epidemiology and survival outcomes for eyelid primary malignant melanoma: an analysis of 1397 cases in the SEER database. J\u00a0Ophthalmol 2020:4858636. https:\/\/doi.org\/10.1155\/2020\/4858636","journal-title":"J Ophthalmol"},{"key":"1820_CR35","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.2147\/OTT.S130371","volume":"10","author":"Y Shi","year":"2017","unstructured":"Shi\u00a0Y, Jia\u00a0R, Fan\u00a0X (2017) Ocular basal cell carcinoma: a\u00a0brief literature review of clinical diagnosis and treatment. Onco Targets Ther 10:2483\u20132489. https:\/\/doi.org\/10.2147\/OTT.S130371","journal-title":"Onco Targets Ther"},{"issue":"6","key":"1820_CR36","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S1470-2045(21)00126-1","volume":"22","author":"AJ Stratigos","year":"2021","unstructured":"Stratigos\u00a0AJ, Sekulic\u00a0A, Peris\u00a0K et al (2021) Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial. Lancet Oncol 22(6):848\u2013857. https:\/\/doi.org\/10.1016\/S1470-2045(21)00126-1","journal-title":"Lancet Oncol"},{"issue":"4","key":"1820_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/IIO.0b013e3181b7ecd1","volume":"49","author":"TJ Sullivan","year":"2009","unstructured":"Sullivan\u00a0TJ (2009) Squamous cell carcinoma of eyelid, periocular, and periorbital skin. Int Ophthalmol Clin 49(4):17\u201324. https:\/\/doi.org\/10.1097\/IIO.0b013e3181b7ecd1","journal-title":"Int Ophthalmol Clin"},{"issue":"5","key":"1820_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1524-4725.2007.34115.x","volume":"34","author":"MK Thosani","year":"2008","unstructured":"Thosani\u00a0MK, Schneck\u00a0G, Jones\u00a0EC (2008) Periocular squamous cell carcinoma. Dermatol Surg 34(5):585\u2013599. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.34115.x","journal-title":"Dermatol Surg"},{"issue":"6","key":"1820_CR39","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jaad.2016.07.046","volume":"75","author":"R Tripathi","year":"2016","unstructured":"Tripathi\u00a0R, Chen\u00a0Z, Li\u00a0L, Bordeaux\u00a0JS (2016) Incidence and survival of sebaceous carcinoma in the United States. J\u00a0Am Acad Dermatol 75(6):1210\u20131215. https:\/\/doi.org\/10.1016\/j.jaad.2016.07.046","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1820_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/0974-620X.71885","volume":"3","author":"UK Wali","year":"2010","unstructured":"Wali\u00a0UK, Al-Mujaini\u00a0A (2010) Sebaceous gland carcinoma of the eyelid. Oman J Ophthalmol 3(3):117\u2013121. https:\/\/doi.org\/10.4103\/0974-620X.71885","journal-title":"Oman J Ophthalmol"},{"issue":"12","key":"1820_CR41","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00347-016-0387-5","volume":"113","author":"M Weiling","year":"2016","unstructured":"Weiling\u00a0M, Bergua\u00a0A, Kruse\u00a0FE, Holbach\u00a0L (2016) Therapie bei malignen Lidtumoren. Ophthalmologe 113(12):1095\u20131108. https:\/\/doi.org\/10.1007\/s00347-016-0387-5","journal-title":"Ophthalmologe"},{"issue":"7","key":"1820_CR42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/ceo.12298","volume":"42","author":"A Wu","year":"2014","unstructured":"Wu\u00a0A, Sun\u00a0MT, Huilgol\u00a0SC, Madge\u00a0S, Selva\u00a0D (2014) Histological subtypes of periocular basal cell carcinoma. Clin Experiment Ophthalmol 42(7):603\u2013607. https:\/\/doi.org\/10.1111\/ceo.12298","journal-title":"Clin Experiment Ophthalmol"},{"issue":"5","key":"1820_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/jamaophthalmol.2019.0238","volume":"137","author":"S Xu","year":"2019","unstructured":"Xu\u00a0S, Sagiv\u00a0O, Rubin\u00a0ML, Sa\u00a0H\u2011S, Tetzlaff\u00a0MT, Nagarajan\u00a0P, Ning\u00a0J, Esmaeli\u00a0B (2019) Validation study of the AJCC cancer staging manual, eighth edition, staging system for eyelid and periocular squamous cell carcinoma. JAMA Ophthalmol 137(5):537\u2013542. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.0238","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"1820_CR44","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.jaad.2018.12.053","volume":"80","author":"C Zhou","year":"2019","unstructured":"Zhou\u00a0C, Wu\u00a0F, Chai\u00a0P, Shi\u00a0Y, Ye\u00a0J, Shi\u00a0X, Tan\u00a0J, Ding\u00a0Y, Luo\u00a0Y, Esmaeli\u00a0B, Jia\u00a0R, Fan\u00a0X (2019) Mohs micrographic surgery for eyelid sebaceous carcinoma: a multicenter cohort of 360\u00a0patients. J\u00a0Am Acad Dermatol 80(6):1608\u20131617.e1. https:\/\/doi.org\/10.1016\/j.jaad.2018.12.053","journal-title":"J Am Acad Dermatol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01820-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-023-01820-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01820-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T04:03:08Z","timestamp":1697601788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-023-01820-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1820"],"URL":"https:\/\/doi.org\/10.1007\/s00347-023-01820-w","relation":{"has-translation":[{"id-type":"doi","id":"10.1007\/s00347-023-01945-y","asserted-by":"object"}]},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"assertion":[{"value":"23 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Gniesmer, S.R.\u00a0Sonntag, C.\u00a0Schiemenz, M.\u00a0Ranjbar, L.M.\u00a0Heindl, M.A.\u00a0Varde, S.\u00a0Emmert, S.\u00a0Grisanti und V.\u00a0Kakkassery geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}